Kai Wille

15PUBLICATIONS
101CO-AUTHORS
Haematological tumoursCardiology (incl. cardiovascular diseases)Predictive and prognostic markersAfrican languagesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 23, 2026
Ibrutinib and standard immunochemotherapy in younger, high-risk patients with diffuse large B-cell lymphoma: A phase II study of GLA.

|Sep 18, 2026
Loncastuximab tesirine in heavily pretreated patients with large B-cell lymphoma: a German Lymphoma Alliance analysis.

|Jul 10, 2026
Shortening of central venous catheter time in men with hematological and oncological diseases for prevention of central venous catheter-related bloodstream infections: a target-trial-emulation study.

|Sep 27, 2025
Prognostic Role of Kidney Disease in Newly Diagnosed Acute Myeloid Leukemia Under Venetoclax-Based Low-Intensity Therapy.

Katja Krüger, Razif Gabdoulline, Martin Wichmann

|Dec 11, 2024
Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study.

Evgenii Shumilov, Rebecca Wurm-Kuczera, Andrea Kerkhoff

|Sep 10, 2024
Venetoclax Combined With FLAG-IDA in Refractory or Relapsed Acute Myeloid Leukemia.

Kai Wille, Marvin Dumke, Nadine Wilsdorf

Pageof 3

Frequent Collaborators

3 joint publications

Evgenii Shumilov

2 joint publications

Alexander Sebastian Hölscher

2 joint publications

Sascha Dietrich

2 joint publications

Bastian von Tresckow